Drug intelligence / Profile preview

proquazone

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Proquazone is a nonsteroidal anti-inflammatory drug (NSAID) of the quinazolinone class, used primarily for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and other musculoskeletal disorders. It has also been trialed for acute pain states such as dysmenorrhea, postoperative pain, and headache. Unlike most NSAIDs, it does not have a free acid group in its structure. Its mechanism of action includes inhibition of cyclooxygenase enzymes (COX), leading to reduced synthesis of prostaglandins involved in inflammation and pain signaling[1][5]. Additionally, it inhibits core protein synthesis of proteoglycans and secondary biosynthesis of glycosaminoglycan chains in cartilage tissue[6][8]. Proquazone is considered comparable in efficacy to other NSAIDs but may cause gastrointestinal side effects such as diarrhea[5].

Brand names
ArthrexBiarisonProzolex
Other names
proquazonumproquazona7-methyl-1-(1-methylethyl)-4-phenylquinazolinone1-isopropyl-7-methyl-4-phenylquinazolinone
02

Targets

COXGlycosaminoglycan chain biosynthetic machinery

Beyond the preview

Go deeper on proquazone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on proquazone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call